Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)

Bicycle Therapeutics posted quarterly Asset Utilization Ratio of 0.09 for Q1 2026, up 231.68% year-on-year from 0.03 in Q1 2025, and down 5.4% on a QoQ basis from 0.1 in Q4 2025.

Bicycle Therapeutics (BCYC) has 8 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 231.68% year-over-year to 0.09; the trailing twelve-month figure through Mar 2026 stood at 0.09 (up 231.68% YoY), and the FY2025 full-year result was 0.09, up 90.75% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.09, down from 0.1 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.1 in Q4 2025 and bottomed at 0.02 in Q2 2025.
  • The 5-year median for Asset Utilization Ratio is 0.04 (2022), against an average of 0.05.
  • The widest annual swing landed in 2022, when Asset Utilization Ratio plunged 57.13%; it then jumped 266.09% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2022, then retreated by 23.65% to 0.04 in 2023, then sank by 38.78% to 0.03 in 2024, then surged by 266.09% to 0.1 in 2025, then slipped by 5.4% to 0.09 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.1 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.47
7 Evaxion A 64.16 Bn 64.14 Bn - 0.29
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.85
10 Bicycle Therapeutics 326.82 Mn 326.82 Mn - 0.09

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.09
Dec 31, 2025 0.10
Sep 30, 2025 0.04
Jun 30, 2025 0.02
Mar 31, 2025 0.03
Dec 31, 2024 0.03
Sep 30, 2024 0.03
Jun 30, 2024 0.04
Mar 31, 2024 0.06
Dec 31, 2023 0.04
Sep 30, 2023 0.05
Jun 30, 2023 0.06
Mar 31, 2023 0.06
Dec 31, 2022 0.06
Sep 30, 2022 0.04
Jun 30, 2022 0.04
Mar 31, 2022 0.02
Dec 31, 2021 0.03
Sep 30, 2021 0.05
Jun 30, 2021 0.05
Mar 31, 2021 0.06
Dec 31, 2020 0.06
Sep 30, 2020 0.08
Jun 30, 2020 0.07
Mar 31, 2020 0.07
Dec 31, 2019 0.12
Sep 30, 2019 0.08